National Cancer Institute is a clinical research site located in Bethesda, Maryland, United States 20892.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
National Cancer Institute has participated in 51 clinical trials with 12 currently active.
Therapeutic areas: Solid Metastatic Tumor, Prostate Adenocarcinoma, Urinary Bladder Neoplasms.
Sponsors: Bavarian Nordic, Alessa Therapeutics Inc., Icahn School of Medicine at Mount Sinai.
Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
National Cancer Institute has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
National Cancer Institute has 51 clinical trials on record, with 12 currently active. Their work covers Solid Metastatic Tumor, Prostate Adenocarcinoma, Urinary Bladder Neoplasms.
National Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.